The largest database of trusted experimental protocols

Nzy m mulv first strand cdna synthesis kit

Manufactured by NZYTech
Sourced in Portugal

The NZY M-MuLV First-Strand cDNA Synthesis kit is a laboratory tool used for the reverse transcription of RNA into complementary DNA (cDNA). The kit contains the necessary components, including the M-MuLV reverse transcriptase enzyme, to facilitate this process.

Automatically generated - may contain errors

13 protocols using nzy m mulv first strand cdna synthesis kit

1

Gene Expression Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For gene expression analysis, total RNA was isolated with Trizol Reagent (Invitrogen). Template cDNA synthesis was performed using the NZY M-MuLV First-Strand cDNA Synthesis Kit (Nzytech, Lisbon, Portugal). Quantitative reverse transcription-PCR (qRT-PCR) was performed with the KAPA SYBR Fast Universal Kit from Sigma-Aldrich. (Madrid, Spain) All primers were purchased from Sigma-Aldrich and are described in Table S1.
+ Open protocol
+ Expand
2

Quantitative RT-PCR Analysis of Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA extraction was carried out using NZY Total RNA Isolation Kit (Nzytech, Caparica, Portugal) following the instructions of the manufacturer. We used 100 ng of RNA for retrotranscription using NZY M-MuLV First-Strand cDNA synthesis kit (Nzytech, Caparica, Portugal). Real-time qPCR was carried out using PowerUp SYBR Green Master Mix (ThermoFisher, Waltham, USA), 1 μl of 1:10 cDNA dilution, and the primers shown in Supplementary Table S3. The reaction was performed using a total volume of 15 μl in a Step-One Plus Real-Time PCR system (ThermoFisher, Waltham, USA), cycling conditions were as follows: 50°C for 2 min, 95°C for 2 min, 40 cycles of 95°C for 15 s, and 30 s at 60°C; followed by a melting curve. To normalize the expression of the KLF4, VDR, PPARγ, and EDN1, we followed the–ΔCT method using YWHAZ and ALAS1 as reference genes.
+ Open protocol
+ Expand
3

Lumbosacral DRG Neuron RNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lumbosacral DRG neurons (L5-S1) were homogenized using a MagNa Lyser Instrument (Roche Diagnostics, Mannheim, Germany) and 1.4 mm ceramic beads (Qiagen, Hilden, Germany)). Total RNA was extracted from L5-S1 DRG tissue using the RNAqueous®-Micro kit (Applied Biosystems, Bedford, MA, USA). An aliquot of each RNA sample was run on a denaturing agarose gel to assess integrity. Intact RNA was then quantified by NanoDrop 2000 (Thermo Scientific, Waltham, MA, USA), followed by treatment with DNase. DNase-treated RNA (500 ng) was reverse transcribed using the NZY M-MuLV First-Strand cDNA Synthesis Kit (NZYtech, Lisbon, Portugal), according to the manufacturer’s instructions. cDNA was diluted and stored at −20 °C for later use.
+ Open protocol
+ Expand
4

Anti-inflammatory Activity of Fucopol HMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The analysis of the anti-inflammatory activity of the Fucopol HMs in THP1 cells proceeded as previously described with a few modifications [66 (link)]. Briefly, 1 × 106 THP1 cells were seeded in 6-well plates, incubated for 2 h with 7 µg/mL Lipopolysaccharide (LPS, Sigma Aldrich, St. Louis, MO, USA) and were then incubated for 30 min or 3 h with the Fucopol HMs (13 mm diameter) or with 500 µg/mL of Fucopol. Identical samples without the addition of LPS were prepared (-LPS) for negative control purposes. In another approach, cells were simultaneously exposed for 2 h to both LPS and the Fucopol HMs or to 500 µg/mL of Fucopol. After the incubation time, cells were pelleted via centrifugation (500× g, 5 min) and solubilized in 300 µL of NZYol (NZYtech, Lisboa, Portugal), and RNA was extracted according to the manufacturer’s instructions and reverse-transcribed with the NZY M-MulV First strand cDNA synthesis kit (NZYtech). The relative expression of the tumor necrosis factor α gene (TNF-α) and of the housekeeping gene RNA18S were determined using the Ct method (2−∆∆Ct) [67 (link)] after real-time quantitative amplification using the NZYSupreme qPCR Green Master Mix (NZYtech) in a Corbett Rotor-Gene thermal cycler (Qiagen, Hilden, Germany).
+ Open protocol
+ Expand
5

RNA Extraction and qPCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted with the NZY Total RNA Isolation kit (Nzytech), according to manufacturer’s instructions, quantified in a NanoDrop spectrophotometer (Thermo Fischer Scientific), and treated with RQ1 RNase-free DNase (Promega) for 30 min at 37°C, in accordance with manufacturer instructions. All primers, except TaqMan probes, were synthesized by Thermo Fisher. DNase I-treated RNA was reverse transcribed using the NZY M-MuLV First-Strand cDNA Synthesis kit (Nzytech) and Oligo(dT)20 primers. cDNA was amplified by real-time PCR using TaqMan Gene Expression Master Mix (Applied Biosystems) or NZYSupreme qPCR Green Master Mix (2x), ROX plus (Nzytech), according to manufacturer’s instructions. For primer details, see Table S5. PrimerBank sequences were obtained from https://pga.mgh.harvard.edu/primeRbank/.
+ Open protocol
+ Expand
6

Quantitative Analysis of Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells exposed to the different conditions (AuNP@PEG and Au-nanoconjugate) in 24-well plates were collected at different time points between 3 and 72 hr. Cells were centrifuged at 200 × g for 5 min at room temperature, and total RNA was extracted from cell pellets using TRIsure (Bioline) according to the manufacturer’s instructions. Total RNA (100 ng) was reverse transcribed using the NZY M-MuLV First-Strand cDNA Synthesis kit (NZYTech).
qPCR amplification of cDNA was performed on a Corbett Rotor-Gene 6000 thermal cycler (QIAGEN) using the HOT FIREpol EvaGreen qPCR Mix (Solis BioDyne) with the following primers, at a concentration of 100 nM each: BCR forward (5′-GAAGTGTTTCAGAAGCTTCTCC-3′) and ABL1 reverse (5′-GTTTGGGCTTCACACCATTCC-3′); BCL2 forward (5′-CTTCGCCGAGATGTCCAGCCA-3′) and BCL2 reverse (5′-CGCTCTCCACACACATGACCC-3′); 18S forward (5′-GTAACCCGTTGAACCCCATT-3′) and 18S reverse (5′-CCATCCAATCGGTAGTAGCG-3′). qPCR conditions included an initial denaturation at 95°C for 15 min and 40 cycles of 95°C for 20 s, 55°C (BCR-ABL1 and 18S) or 65°C (BCL-2) for 20 s, and 72°C for 30 s. qPCR data were analyzed by the Ct method (2−ΔΔCt), where relative gene expression is given by quantification of the gene of interest (BCR-ABL1 or BCL2) relative to internal control gene (18S), normalized to the control condition (cells exposed to AuNP@PEG).43 (link)
+ Open protocol
+ Expand
7

cDNA Synthesis from Total RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cDNA was synthesized from 100 ng of RNA using an NZY M-MuLV First-Strand cDNA Synthesis Kit (NZYtech, Lisbon, Portugal) for a final volume of 10 µL. Samples were incubated in DNA Engine® Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, USA) at 25 °C for 10 min, 37 °C for 50 min, and 85 °C for 5 min. Afterwards, 0.5 µL of RNase H (NZYtech, Lisbon, Portugal) was added and samples were stirred in a vortex and incubated in a heat block at 37 °C for 20 min. The synthetized cDNA was stored at −20 °C for further analysis.
+ Open protocol
+ Expand
8

Gene Expression Analysis of Breast Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells or mouse tumors total RNA was extracted using the NZY Total RNA Isolation kit (#MB13402, Nzytech). RNA from human breast tumors was obtained from Biobanco-iMM. DNase I-treated RNA was reverse transcribed using the NZY M-MuLV First-Strand cDNA Synthesis kit (#MB17301, Nzytech) and Oligo (dT)20 primer; and cDNAs were amplified by real-time PCR using TaqMan Gene Expression Master Mix (#4369016, Applied Biosystems) or NZY qPCR Green, ROX (#MB22003, Nzytech). Specific primers included: TNFRSF11A (#Hs00921372_m1, Applied Biosystems), TNFSF11 (#Hs00243522_m1, Applied Biosystems), PGR (#Hs01556702_m1, Applied Biosystems), ESR1 (#Hs01046816_m1, Applied Biosystems), Twist (Fw: 5′-ccggagacctagatgtcattg-3′; Rv: 5′-ccacgccctgtttctttg-3′), Slug (Fw: 5′-ccaaactacagcgaactgga-3′; Rv: 5′-gtggtatgacaggcatggag-3′), Vimentin (Fw: 5′-gaaaacaccctgcaatctt-3′; Rv: 5′-cctggatttcctcttcgtg-3′), N-cadherin (Fw: 5′-tatcgaaggatgtgcatga-3′; Rv: 5′-caggctcactgctctcata-3′), Oct4 (Fw: 5′-ctgagggcgaagcaggagtc-3′; Rv: 5′-cttggcaaattgctcgagtt-3′) and GAPDH (#PPH00150F, SA Biosciences). Gene expression was normalized using the housekeeping gene GAPDH, and relative mRNA expression was calculated using the 2–ΔΔCt method.
+ Open protocol
+ Expand
9

Total RNA Extraction and qPCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from CAM using TRIsure™ Reagent method (Bioline, London, UK) according to the manufacturer’s instructions. The quality of RNA was assessed using the Nanodrop ND-1000 Spectrophotometer (ThermoScientific, Wilmington, DE). Total RNA extracted from samples was reverse transcribed using the NZY M-MuLV First-Strand cDNA Synthesis kit (Nzytech, Lisbon, PT) followed by qPCR amplification using KAPA SYBR® FAST kit (KAPAbiosystems, Cape Town, SA). The following conditions were used: initial denaturation at 95 °C for 5 min; 40 cycles of 95 °C for 30 s, Tm  °C for 30 s, 72 °C for 1 min; and a final extension step at 72 °C for 10 min. The Tm temperature varied from set of primers, as described in Additional file 1: Table S1.5.
+ Open protocol
+ Expand
10

Hypoxia and Inflammation Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inflammation and hypoxia markers HIF1A, RELA, VEGFA, MMP2, CTSD, IL6, and TNFA genes expression was assessed by reverse transcription quantitative polymerase chain reaction (RT-qPCR). First, total RNA was extracted from 10 spheroids of each condition using SV Total RNA Isolation System (Promega Corporation, United States). Then, complementary DNA (cDNA) synthesis was achieved using NZY M-MulV First-Strand cDNA Synthesis Kit (nzytech, Portugal), following the manufacturer’s recommendations. cDNA amplification was performed using Rotor-Gene (Qiagen, Germany), using NZYSupreme qPCR Green Master Mix (2x) (nzytech, Portugal). The primers sequences and qPCR cycling programs used to evaluate each gene expression are described in the (Supplementary Tables S1, S2).
The RT-qPCR was used as endogenous control. Relative levels of gene expression were quantified based on the 2−ΔΔCT method (Schmittgen and Livak, 2008 (link)), using the 18S ribosomal RNA (18S) gene as endogenous control (Schmittgen and Zakrajsek, 2000 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!